A company discovering new drugs for a range of diseases based on the genomes of hibernating animals is raising $9 million in seed funds. . . . → Read More: Animal Genome Biotech Raises $9M in Seed Funds
|
|||||
       
  |
A company developing a one-time treatment for HIV infections using the gene-editing technique Crispr says it received FDA clearance to begin a clinical trial. . . . → Read More: FDA Okays One-Time HIV Treatment Clinical Trial 
A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies. . . . → Read More: Gene-Edited Treatments in Works for Safer Cancer Therapies 
A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases. . . . → Read More: Pharma, Synthetic Bio Companies to Find Antibody Therapies 
A company designing synthetic viruses that attack antibiotic-resistant bacteria is receiving National Science Foundation funds to advance its work. . . . → Read More: Small Biz Grant Funds Superbug Therapy Technology  Comments are closed  Finance, New products  biomedical, biotechnology, entrepreneurs, genomics, grant, life sciences, mathematics, NSF, pharmaceuticals, physical sciences 
A blood test analyzed with algorithms is shown to detect more than 90 percent of early-stage lung cancer cases in people at high risk of the disease. . . . → Read More: AI-Analyzed Liquid Biopsy IDs Early Lung Cancer Comments are closed New products biomedical, cancer, clinical trials, engineering, entrepreneurs, Europe, genomics, life sciences, mathematics, medical device, physical sciences, university 
A biotechnology company is advancing a vaccine to protect against disease from SARS-CoV-2 variants, with new support from the organization CEPI. . . . → Read More: CEPI Funding Covid-19 Variant Vaccine One comment - (Comments are closed) Finance, New products Africa, biomedical, biotechnology, clinical trials, Covid-19, Europe, genomics, grant, life sciences, pharmaceuticals, preclinical 
A one year-old biotechnology company developing treatments for diseases of microglia cells in the brain, is raising $90 million in new venture funds. . . . → Read More: Biotech Start-Up Gains $90M for Neurodegenerative Diseases Comments are closed Finance, New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, preclinical, university, venture capital 
Two biotechnology companies are designing new processes to produce ingredients much like those found in drugs made from plants for essential medicines. . . . → Read More: Biotechs Partner on Synthetic Plant-Based Drugs One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, engineering, entrepreneurs, genomics, health care, life sciences, manufacturing, mathematics, pharmaceuticals, university 
The biotechnology company Moderna Inc. agreed to build a manufacturing plant for its messenger RNA or mRNA vaccines in Canada. . . . → Read More: Moderna to Build mRNA Vaccine Plant in Canada One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, Canada, Covid-19, genomics, life sciences, manufacturing, pharmaceuticals |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
